Holly A Quasny (Holly Quasny)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Randomized Controlled Trial

Systemic Lupus Erythematosus

Top Venues

Lupus science & medicine

International journal of rheumatic diseases

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases 27 (1) (2023)
Ken-Ei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly A Quasny, Roger Abramino Levy, Angela R Jones-Leone, Kerry Gairy, Nobuyuki Yajima
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT. Lupus science & medicine 9 (1) (2023)
Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases 27 (1) (2023)
Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases (2023)
Michelle A Petri, Helain Landy, Megan E B Clowse, Kim Gemzoe, Munther Khamashta, Milena Kurtinecz, Roger Abramino Levy, Andrew Liu, Rebecca Marino, Paige Meizlik, Jeanne M Pimenta, Kelsey Sumner, Hugh Tilson, Mary Beth Connolly, Keele Wurst, Julia Harris, Holly A Quasny, Patricia Juliao, David A Roth
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. Annals of the rheumatic diseases (2022)
Jacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, Anna Richards, Yun Irene Gregan, Holly A Quasny, Deven Chauhan
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study. Lupus science & medicine 9 (1) (2022)
Ronald F Van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger Abramino Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao, Richard A Furie
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus science & medicine 9 (1) (2022)
Hermine I Brunner, Carlos Abud Mendoza, Masaaki Mori, Clarissa A Pilkington, Reema Syed, Syuji Takei, Diego O Viola, Richard A Furie, Sandra V Navarra, Fengchun Zhang, Damon L Bass, Gina Eriksson, Anne E Hammer, Beulah N Ji, Mohamed Okily, David A Roth, Holly A Quasny, Nicolino Ruperto
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. RMD open 7 (3) (2021)